Preferred Plus Mucus Er label

Preferred Plus Mucus Er

Preferred Plus Mucus Er Recall

Get an alert when a recall is issued.

Side Effects & Adverse Reactions

Do not use

•
for children under 12 years of age

Ask a doctor before use if you have

•
persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
•
cough accompanied by too much phlegm (mucus)

Stop use and ask a doctor if

•
cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness.

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

Do not use

•
for children under 12 years of age

Ask a doctor before use if you have

•
persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
•
cough accompanied by too much phlegm (mucus)

Stop use and ask a doctor if

•
cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive

History

There is currently no drug history available for this drug.

Other Information

There are no additional details available for this product.

Preferred Plus Mucus Er Manufacturers

  • Preferred Plus Mucus Er | Basiem
    No Recall

    Preferred Plus Mucus Er | Basiem

    Preferred Plus Mucus Er | Basiem
    DOSAGE AND ADMINISTRATION

    For most patients, the recommended dose of cyclobenzaprine hydrochloride tablets, USP is 5 mg three times a day. Based on individual patient response, the dose may be increased to 10 mg three times a day. Use of cyclobenzaprine hydrochloride tablets, USP for periods longer than two or three weeks is not recommended (see INDICATIONS AND USAGE).
    Less frequent dosing should be considered for hepatically impaired or elderly patients (see PRECAUTIONS, Impaired Hepatic Function, and Use in the Elderly).

    DOSAGE AND ADMINISTRATION

    Apply MaC Patch to intact skin to cover the area most sensitive to pain. Each patch should not be applied for more than 8 hours in a given 24-hour period. Patches may be cut into smaller sizes with scissors prior to removal of the release liner. Clothing may be worn over the area of application. Smaller areas of treatment are recommended in a debilitated patient, or a patient with impaired elimination.

    If irritation or a burning sensation occurs during application, remove the patch and do not reapply until the irritation subsides. When MaC Patch is used concomitantly with other products containing same or similar agents, the amount absorbed from all formulations must be considered